Optimum Investment Advisors Intellia Therapeutics, Inc. Transaction History

Optimum Investment Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$10.43 - $17.67 $3,129 - $5,301	-300 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$13.07 - $18.51 $13,070 - $18,510	-1,000 Reduced 76.92%	300 $4,000
Q4 2018 Feb 04, 2019	SELL	$11.39 - $27.13 $5,695 - $13,565	-500 Reduced 27.78%	1,300 $18,000
Q3 2018 Oct 05, 2018	SELL	$25.78 - $32.6 $2,578 - $3,260	-100 Reduced 5.26%	1,800 $52,000
Q1 2018 May 09, 2018	BUY	$19.43 - $34.95 $36,917 - $66,405	1,900 New	1,900 $40,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.